Volunteers deliver food to Oakland County seniors on World Alzheimer's Day
More than 100 volunteers gathered on Monday to distribute fresh food and Alzheimer's education resources to seniors in Oakland County in recognition of World Alzheimer's Day.
Watch CBS News
More than 100 volunteers gathered on Monday to distribute fresh food and Alzheimer's education resources to seniors in Oakland County in recognition of World Alzheimer's Day.
A Brighton, Michigan, man bicycling his way across the state to raise awareness about Alzheimer's wrapped up his weeklong ride on Sunday.
Brown Adult Day Program will host a speaker and tour at its Southfield facility on the topic "Alzheimer's through the stages: A guide for patients and families."
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of cognitive decline.
Neighbors are collecting cards for John Reichart and his wife — find out how to send one here.
Cissy Houston performed alongside superstar musicians like Elvis Presley and Aretha Franklin.
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
Scientists studying a Colombian family plagued by early-in-life Alzheimer's have found a rare gene variant that seems to delay initial symptoms by about five years.
The FDA granted full approval to Alzheimer's treatment Leqembi on July 6.
Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer's disease. It first received an accelerated approval from the FDA earlier this year.
Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab.
Leqembi, from Japan's Eisai and its U.S. partner Biogen, is a rare success in a field accustomed to failed experimental treatments for the incurable condition.
A half hour of aerobic exercise four to five times a week may prevent or slow cognitive decline in older adults who are at a high risk of developing Alzheimer's, according to a study published Tuesday in the Journal of Alzheimer's Disease.
Scientists found that apoE4 is only slightly different from the gene apoE3 however, the protein it produces within the body is much more damaging to human brain cells.
Could changes in your verbal pattern over time be an early indicator for Alzheimer's disease?
Authorities say 67-year-old northern Michigan man stole more than $100,000 from an elderly woman who was diagnosed with Alzheimer's disease while he was serving as a lawyer.
A recent study finds that while many caregivers believe taking care of a loved one at home has provided more meaning in their life, a majority often feel alone, exhausted, frustrated and overwhelmed.
Metabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer's Drug Discovery.
Police are asking for the public's help in finding a missing 79-year-old Farmington Hills man with Alzheimer's disease.
A senior University of Michigan medical school faculty member linked to a $276 million insider trading case has retired.
Radiation is often thought of for just treating cancer, but a new groundbreaking Beaumont study finds in mice that it can treat Alzheimer's.
A Grand Valley State University faculty member received a National Institutes of Health grant to continue researching how patients with Alzheimer's disease use visual cues to navigate their living areas.
Metabolic Solutions Development Co. LLC will provide an update on the clinical evaluation of MSDC-0160, a compound being investigated in an ongoing Phase 2a trial in subjects with mild to moderate dementia due to Alzheimer's disease, at the Alzheimer's Drug Discovery Foundation 13th International Conference on Alzheimer's Drug Discovery in Jersey City, N.J. Sept. 10.
An Alzheimer's patient is missing and Inkster police are asking for your help in finding her.
Tetra Discovery Partners LLC, a developer of new treatments for major neurological conditions based on PDE4 modulation in the brain, announced it has been awarded a five-year cooperative agreement by the National Institutes of Health. \
